Each year, malaria claims over 600,000 lives, with most fatalities occurring among children in Sub-Saharan Africa (World Health Organization [WHO], 2024). For decades, medicines developers have fought an arms race against Plasmodium parasites, developing new therapies only to watch resistance emerge. A recent breakthrough from the University of California, San Francisco (UCSF) offers hope that we may stay ahead in this race.

The Challenge of Drug Resistance

The current gold standard, artemisinin-based combination therapy (ACT), has saved countless lives. However, artemisinin resistance, once confined to Southeast Asia, is now spreading into Africa, where 95% of cases and deaths occur (University of California – San Francisco, 2025). Artefenomel, a potent artemisinin-inspired compound, was intended to replace ACT, potentially curing malaria with a single dose. Unfortunately, its poor solubility made it difficult to administer, particularly to children, and it was withdrawn from clinical trials in early 2025 (University of California – San Francisco, 2025).

A Chemical Makeover with Big Potential

UCSF chemists hypothesized that artefenomel’s high molecular symmetry caused it to clump into slow-dissolving crystals. By reducing its symmetry, they created a variant that dissolved instantly, was easy to formulate into pills, and retained potency against both sensitive and drug-resistant parasites. In laboratory and animal tests, and in in vitro assays using blood from Ugandan patients, the optimized molecule proved as potent as artefenomel and more effective than artemisinin against resistant strains (University of California – San Francisco, 2025).

“We’re optimistic that a simple chemical change like this can pave the way for an effective successor to artemisinin — one that’s cheap to make and easy to combine with other anti-malarial drugs,” said Adam Renslo, PhD, senior author of the study (University of California – San Francisco, 2025).

Competencies and Ethics in Medicines Development

This advance illustrates several key competencies identified in the Grand Challenges in Pharmaceutical Medicine framework (Silva, Stonier, Kerpel-Fronius, & Dubois, 2021):

  • Translational Research Skills — Moving from chemical theory through preclinical models to clinical applicability requires cross-disciplinary expertise.
  • Patient-Centered Problem-Solving — Reformulating artefenomel was motivated by real-world administration challenges in children.
  • Ethical Stewardship —All members of multidisciplinary teams share responsibility for ensuring safety, scientific integrity, and equitable access.
  • Global Health Priority Alignment — Focusing innovation on diseases with the highest burden reflects the profession’s public health obligations.

The Role of Education and Continuous Training

Preparing professionals for such challenges is central to the GMDP Academy’s Certification in Medicines Development, delivered in partnership with King’s College London. This program integrates the scientific, regulatory, and ethical foundations of drug development (Silva et al., 2024) and aligns with globally recognized competency frameworks. By equipping learners to bridge scientific innovation with patient need, the Academy fosters the skills necessary to ensure that advances like this malaria breakthrough reach the communities that need them most.

References

Silva, H., Stonier, P. D., Kerpel-Fronius, S., & Dubois, D. J. (2021). Editorial: Grand challenges in pharmaceutical medicine: Competencies and ethics in medicines development. Frontiers in Pharmacology, 12, 666406. https://doi.org/10.3389/fphar.2021.666406

Silva, H., Stonier, P., Chopra, P., Coots, J., Criscuolo, D., Guptha, S., Jones, S., Kerpel-Fronius, S., Kesselring, G., Luria, X., Morgan, D., Power, E., Salek, S., Silva, G., Suto, T., Thakker, K., & Vandenbroucke, P. (2024). Blended e-learning and certification for medicines development professionals: Results of a 7-year collaboration between King’s College London and the GMDP Academy, New York. Frontiers in Pharmacology, 15, 1417036. https://doi.org/10.3389/fphar.2024.1417036

University of California – San Francisco. (2025, August 11). This chemical trick could turn losing malaria drug into a winner [Press release]. Science Advances. https://www.eurekalert.org/news-releases/1094239

World Health Organization. (2024). World malaria report 2024. World Health Organization. https://www.who.int/publications/i/item/9789240089752

Disclaimers

  • The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
  • Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
  • No official support by any organization(s) has been provided or should be inferred